GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (WBO:BIM) » Definitions » Float Percentage Of Total Shares Outstanding

BioMerieux (WBO:BIM) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioMerieux Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioMerieux's float shares is 0.00 Mil. BioMerieux's total shares outstanding is 118.16 Mil. BioMerieux's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioMerieux's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioMerieux's Institutional Ownership is 18.96%.

BioMerieux Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BioMerieux's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/118.16
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioMerieux (WBO:BIM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (WBO:BIM) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:ERF XPAR:LBIRD XPAR:ALPRE TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT SHSE:603259 LH DGX RVTY MEDP CRL NTRA
Traded in Other Exchanges
BMXMF:USA BIMp:UK 0RUG:UK BIM:France EYWN:Germany
Address
Marcy l’Etoile, Lyon, FRA, 69280
Website
http://www.biomerieux.com
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.

BioMerieux (WBO:BIM) Headlines

No Headlines